BRIEF-Resverlogix announces positive recommendation from data safety monitoring board for Apabetalone phase 3 study

* Resverlogix announces positive recommendation from data safety monitoring board for phase 3 study of Apabetalone (rvx-208)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.